Riskpilot← Back to searchSign inGet full accessABBOTT RAPID DIAGNOSTICS AS
ASActiveOrg 933783405Kjelsåsveien 161, 0884 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 196237 employeeswebshop.no.alere.com
Revenue 2024
NOK 263,7M
-21% vs 2023
EBITDA margin
3.2%
+23% vs 2023
Equity ratio
91.4%
Financial strength
Net profit 2024
NOK 11,2M
+35% vs 2023
| Revenue | NOK 263,7M | -21% |
| EBITDA | NOK 8,6M | +23% |
| Net profit | NOK 11,2M | +35% |
| Total assets | NOK 147M | -38% |
| Equity | NOK 134,4M | -37% |
| Employees | 37 | — |
Legal name
ABBOTT RAPID DIAGNOSTICS AS
Org number
933783405
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
15. januar 1962
Share capital
—
Employees
37 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og daglig leder hver for seg.
Address
Kjelsåsveien 161, 0884 Oslo
Phone
+4724056000
Website
webshop.no.alere.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 471 263 | 737 313 | 563 129 | 332 581 | 263 715 |
| Staff expenses | −64 202 | −74 875 | −5 325 | −6 058 | −7 398 |
| EBITDA | 25 095 | 79 493 | 49 690 | 6 949 | 8 565 |
| Depreciation & amort. | −2 300 | −3 607 | −0 | −0 | −0 |
| EBIT | 22 795 | 75 886 | 49 690 | 6 949 | 8 565 |
| Net financials | −1 908 | 1 299 | 662 | 3 751 | 5 906 |
| Profit before tax | 20 887 | 77 185 | 50 352 | 10 700 | 14 471 |
| Tax | 4 595 | 17 319 | 10 855 | 2 376 | 3 235 |
| Net profit | 16 292 | 59 866 | 39 497 | 8 324 | 11 236 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 300 417 | 310 797 | 311 135 | 238 366 | 146 996 |
| Equity | 106 456 | 166 322 | 205 818 | 214 143 | 134 379 |
| Long-term debt | 75 | 0 | 0 | 0 | 0 |
| Short-term debt | 193 887 | 144 475 | 105 316 | 24 223 | 12 617 |
| Total debt | 193 961 | 144 475 | 105 316 | 24 223 | 12 617 |
EBITDA margin
3.2%
This company
15.8%
Market median
-80% vs market
20202024
Equity ratio
91.4%
This company
38.2%
Market median
+139% vs market
20202024
Return on equity
8.4%
This company
18.4%
Market median
-54% vs market
20202024
Net profit margin
4.3%
This company
8.1%
Market median
-47% vs market
20202024
Asset turnover
1.79×
This company
1.12×
Market median
+60% vs market
20202024
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BL Chief Executive Officer | Chief Executive Officer | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Chairman | 2023 | |
| Former (1) | ||
| Chairman | 2021 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 99.94% | 99.94% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Axis-Shield As
ABBOTT RAPID DIAGNOSTICS AS Board members of ABBOTT RAPID DIAGNOSTICS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Berit Landsend-Holo | Chief Executive Officer | 0 companies |
| Petter Aspaas | Chairman | 0 companies |
| Oddvar Arne Vanberg | Board of Directors | 0 companies |
| Björn Fredrik Anders Björnulfson | Chairman | 0 companies |